中译英

                                            诊断证明

XXX，女，47岁，因“右下腹痛一周”于2016年12月12日就诊与哈尔滨医科大学附属第三医院（黑龙江省肿瘤医院）。入院行相关检查，全腹核磁示：右侧盆腔可见囊实混合性占位；CA₁₂₅： 73,38 u/ml。于2016年12月16日行剖腹探查术，术中快速病理提示：<右卵巢>腺癌.遂行卵巢癌肿瘤细胞减灭术。术后病理：<双卵巢>腺癌，大网膜可见癌组织，余未见转移。手术顺利,术后恢复佳。术后以紫杉醇+卡铂（静脉联合腹腔），化疗6疗程，化疗过程有轻度骨髓抑制，经治疗迅速好转，化疗过程如期结束。

上皮性卵巢癌具有较高的复发几率，鉴于该卵巢癌患者病理类型为高级别（恶性程度高），且术后病理提示已有远处转移，故建议其去更先进技术条件的医疗机构行基因检测及复查，制定相应的预防措施，以减少其复发。

                                                                       主治医师：

                          哈尔滨医科大学附属第三医院（黑龙江省肿瘤医院）妇二科  马荣主任医师

                                               电话： 85-451-85718058    86-131-0093-8267

                                                                       2017-6-17

                                                   Diagnosis certificate

XXX, who was female and aged 47, visited The Third Hospital of Harbin Medical University (Heilongjiang Cancer Hospital) on December 12, 2016 due to the right lower abdominal pain for one week. Examinations were performed after admission, and MRI of the whole abdomen showed cystic and solid masses at the right pelvic cavity. CA123 was 7,338 u/ml. Exploratory laparotomy was performed on December 16, 2016, and the intraoperative fast pathological examination indicated adenocarcinoma of the right ovary. Thus, ovary carcinoma cytoreductive surgery was performed. After surgery, pathological examination showed adenocarcinoma of bilateral ovaries, and cancer tissues were observed at the greater omentum, without metastasis at other sites. The surgery was successful, and good recovery was achieved. 6 cycles of paclitaxel+carboplatin (venous approach combined with abdominal approach) chemotherapy was provided after surgery, and there was mild bone marrow suppression during chemotherapy, which was rapidly improved after corresponding treatment. The chemotherapy was completed on time.

There is a higher recurrence rate of ovarian carcinoma. Given the high pathological grade (highly malignant) of the ovarian cancer and distant metastasis revealed by postoperative pathological examination, gene test and revisit at medical agencies with more advanced technology are suggested, and corresponding preventive measures are formulated to reduce its recurrence.

                                                                                Attending physician:
Ma Rong,consultant at Ward 2 of Obstetrics and Gynecology Department, The ThirdHospital of Harbin Medical University.

                                  Tel.: 85-451-85718058    86-131-0093-8267

                                                                                     June 17, 2017